Literature DB >> 25536226

Serum interleukin-17 in primary Sjögren's syndrome: association with disease duration and parotid gland swelling.

Alessia Alunno1, Onelia Bistoni1, Sara Caterbi1, Elena Bartoloni1, Giacomo Cafaro1, Roberto Gerli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25536226

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  7 in total

1.  Characterization of comprehensive dynamic epigenetic changes during human primary Sjögren's syndrome progression.

Authors:  Ningning Cao; Huan Shi; Chan Chen; Lisong Xie; Zhijun Wang; Lingyan Zheng; Chuangqi Yu
Journal:  Ann Transl Med       Date:  2021-07

2.  A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.

Authors:  Sarah Benchabane; Abdelhalim Boudjelida; Ryma Toumi; Houda Belguendouz; Pierre Youinou; Chafia Touil-Boukoffa
Journal:  Int J Immunopathol Pharmacol       Date:  2016-05-19       Impact factor: 3.219

3.  Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study.

Authors:  A Alunno; F Carubbi; O Bistoni; S Caterbi; E Bartoloni; P Di Benedetto; P Cipriani; R Giacomelli; R Gerli
Journal:  Clin Exp Immunol       Date:  2016-03-03       Impact factor: 4.330

Review 4.  T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives.

Authors:  Alessia Alunno; Francesco Carubbi; Onelia Bistoni; Sara Caterbi; Elena Bartoloni; Giulia Mirabelli; Francesca Cannarile; Paola Cipriani; Roberto Giacomelli; Roberto Gerli
Journal:  Mediators Inflamm       Date:  2015-04-28       Impact factor: 4.711

5.  Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome.

Authors:  Yuzhou Gan; Xiaozhen Zhao; Jing He; Xu Liu; Yun Li; Xiaolin Sun; Zhanguo Li
Journal:  J Immunol Res       Date:  2017-01-22       Impact factor: 4.818

Review 6.  Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter?

Authors:  Elena Bartoloni; Alessia Alunno; Giacomo Cafaro; Valentina Valentini; Onelia Bistoni; Angelo Francesco Bonifacio; Roberto Gerli
Journal:  Front Immunol       Date:  2019-04-17       Impact factor: 7.561

7.  Qing Zao Fang (QZF) Alleviates the Inflammatory Microenvironment of the Submandibular Gland in Sjögren's Syndrome Based on the PI3K/Akt/HIF-1α/VEGF Signaling Pathway.

Authors:  Ping Zeng; Wei Liu; Xiaochun Yang; Shumin Zhang; Shaopeng Du; Yihua Fan; Longmei Zhao; Aihua Wang
Journal:  Dis Markers       Date:  2022-01-31       Impact factor: 3.434
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.